Optimizing Bronchopulmonary Cancer Screening — OPTI-DEPIST  

Diagnoses Disease Clinical Trial

Official title: Optimizing the Implementation of Bronchopulmonary Cancer Screening in the Ile de France Region (OPTI-DEPIST-MUT)

Status Not yet recruiting

Clinical Trial Summary

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and strutured network in the pilot centers participating in the study.

Clinical Trial Description

The organization of bronchopulmonary cancer screening in the Ile de France region, within the Mutualité and its affiliated health centers, is based on a clear, simple and functional process:

• Definition of eligibility criteria for screening, based on those of the NELSON study,

• Referral and consultation by a health center physician trained in these criteria,

• Referral and performance of a chest CT scan according to the same recommendations,

• Structured centralized reading and interpretation of CT scan images,

• Referral to a multidisciplinary team (CITT), if bronchopulmonary cancer is suspected,

• Referral to a tobaccology unit in a health center for smokers who have not stopped smoking,

• Organization of follow-up and continuation of the screening program. ;

Related Conditions & MeSH terms

• Bronchopulmonary Disease
• Diagnoses Disease

• NCT number: NCT06439901
• Study type: Interventional
• Source: Institut Curie
• Contact: Catherine DANIEL, MD
• Phone: +33 1 44 32 40 00
• Email: catherine.daniel@curie.fr
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 30, 2024
• Completion date: June 30, 2032